SRZN
#3433
Surrozen, Inc. - Common Stock
22.4 8 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.45%
Variación mensual
-6.26%
Variación en los últimos 6 meses
+9.66%
Cambio anual
+164.16%
Cierres anteriores
22.8 1
Open
22.5 9
Mínimo
22.2 4
High
22.7 9
Volumen
57
Financials
- Market Capitalization 261 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.7
Relación precio/flujo de caja
0.05
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3417 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.37 USD | -2.88% | -4.26% | -3.16% | -32.33% | 268.40 M USD | ||
| 3432 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.98 USD | +0.51% | -15.02% | +24.53% | +330.43% | 266.43 M USD | ||
| 3455 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 8.95 USD | +3.71% | -12.77% | -7.64% | -2.29% | 262.96 M USD | ||
| 3470 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 6.53 USD | -1.06% | -11.76% | -0.91% | -6.31% | 253.50 M USD |